Analysts Set HealthEquity, Inc. (NASDAQ:HQY) PT at $120.27

Shares of HealthEquity, Inc. (NASDAQ:HQY) have been given a consensus recommendation of “Moderate Buy” by the seventeen brokerages that are currently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation, twelve have given a buy recommendation and two have issued a strong buy recommendation on the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $120.2667.

Several brokerages have recently weighed in on HQY. BTIG Research restated a “buy” rating and set a $130.00 price target on shares of HealthEquity in a report on Thursday, December 4th. Royal Bank Of Canada raised their price objective on shares of HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, September 3rd. JPMorgan Chase & Co. upped their target price on shares of HealthEquity from $126.00 to $129.00 and gave the stock an “overweight” rating in a research note on Thursday, December 4th. Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a report on Wednesday, October 8th. Finally, Wall Street Zen lowered shares of HealthEquity from a “buy” rating to a “hold” rating in a report on Saturday, November 15th.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $92.47 on Friday. The company has a 50 day simple moving average of $97.24 and a two-hundred day simple moving average of $96.00. HealthEquity has a fifty-two week low of $74.07 and a fifty-two week high of $116.65. The company has a market capitalization of $7.90 billion, a price-to-earnings ratio of 42.42, a P/E/G ratio of 1.34 and a beta of 0.18. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.11. The company had revenue of $322.16 million for the quarter, compared to the consensus estimate of $320.92 million. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The firm’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.78 EPS. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Analysts expect that HealthEquity will post 2.32 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, EVP Delano Ladd sold 1,500 shares of HealthEquity stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $94.72, for a total value of $142,080.00. Following the completion of the sale, the executive vice president directly owned 73,979 shares in the company, valued at approximately $7,007,290.88. This trade represents a 1.99% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael Henry Fiore sold 1,781 shares of the business’s stock in a transaction dated Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total value of $157,102.01. Following the completion of the transaction, the executive vice president directly owned 49,795 shares of the company’s stock, valued at approximately $4,392,416.95. This trade represents a 3.45% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 17,240 shares of company stock valued at $1,640,164. Corporate insiders own 1.50% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in HQY. Farther Finance Advisors LLC grew its position in HealthEquity by 232.4% in the 2nd quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock worth $26,000 after purchasing an additional 172 shares during the period. Caitong International Asset Management Co. Ltd purchased a new position in shares of HealthEquity in the 2nd quarter worth $33,000. WPG Advisers LLC bought a new stake in shares of HealthEquity in the first quarter worth $28,000. True Wealth Design LLC grew its holdings in shares of HealthEquity by 3,522.2% in the third quarter. True Wealth Design LLC now owns 326 shares of the company’s stock worth $31,000 after acquiring an additional 317 shares during the period. Finally, Cullen Frost Bankers Inc. increased its position in HealthEquity by 172.3% during the second quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock valued at $37,000 after acquiring an additional 224 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.